SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-15-041823
Filing Date
2015-05-12
Accepted
2015-05-12 17:31:29
Documents
1
Period of Report
2015-05-11

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 7993
  Complete submission text file 0001209191-15-041823.txt   9576
Mailing Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803
Business Address 15 NEW ENGLAND EXECUTIVE PARK BURLINGTON MA 01803 781-365-2596
CoLucid Pharmaceuticals, Inc. (Issuer) CIK: 0001348649 (see all company filings)

IRS No.: 203419541 | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900
Business Address TUBORG HAVNEVEJ 19 HELLERUP G7 2900 45 8824 8824
Novo A/S (Reporting) CIK: 0001388325 (see all company filings)

State of Incorp.: G7 | Fiscal Year End: 1231
Type: 4 | Act: 34 | File No.: 001-37358 | Film No.: 15855639